POWERSHARES DYNAMIC PHARMACEUTICALS PORT: (PJP)
(Delayed Data from AMEX) As of Sep 26, 2016 04:09 PM ET
$63.06 USD
-1.29 (-2.01%)
Volume: 102,507
Zacks ETF Rank [?]: 3 - Hold 3
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
| Previous Close | 64.35 |
| Open | 64.00 |
| Bid | 62.62 |
| Ask | 63.36 |
| Day Low-High | 62.97-64.11 |
| 52wk Low-High | 56.70-75.10 |
| Volume | 102,507 |
| NAV (month end) | 64.31 |
| Premium (+)/Discount (-) (month end) | +0.04 |
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
| Expense Ratio | 0.56% |
| Dividend (Yield) | $2.77 (4.31%) |
| Issuer | INVESCO POWERSHARES |
Benchmark for PJP
DYNAMIC PHARMACEUTICALS INTELLIDEX INDEX
The index is comprised of stocks of U.S. pharmaceutical companies. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Fund Summary for PJP
POWERSHARES DYNAMIC PHARMACEUTICALS PORT
It is based on the Dynamic Pharmaceuticals Intellidex Index. It invests at least 90% of its assets in common stocks comprising the Index which provides capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.